Cargando…
The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance
We previously identified the transcription factor ZNF217 (human) / Zfp217 (mouse) as an oncogene and prognostic indicator of reduced survival, increased metastasis, and reduced response to therapy in breast cancer patients. Here we investigated the role of Zfp217 in chemotherapy resistance. Preclini...
Autores principales: | Suarez, Christopher D., Wu, Junmin, Badve, Sunil S., Sparano, Joseph A., Kaliney, William, Littlepage, Laurie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752462/ https://www.ncbi.nlm.nih.gov/pubmed/29312549 http://dx.doi.org/10.18632/oncotarget.19308 |
Ejemplares similares
-
Triciribine Engages ZFP36L1 and HuR to Stabilize LDLR mRNA
por: Sundvold, Hilde
Publicado: (2020) -
The Emerging Role of Zfp217 in Adipogenesis
por: Xiang, Hong, et al.
Publicado: (2017) -
An Expedient Total Synthesis of Triciribine
por: Hu, Chen, et al.
Publicado: (2017) -
Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA
por: Bjune, Katrine, et al.
Publicado: (2018) -
Triciribine attenuates pathological neovascularization and vascular permeability in a mouse model of proliferative retinopathy
por: Shan, Shengshuai, et al.
Publicado: (2023)